0001437749-22-022646.txt : 20220916
0001437749-22-022646.hdr.sgml : 20220916
20220916182437
ACCESSION NUMBER: 0001437749-22-022646
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220914
FILED AS OF DATE: 20220916
DATE AS OF CHANGE: 20220916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kunin Audrey
CENTRAL INDEX KEY: 0001738781
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33678
FILM NUMBER: 221249038
MAIL ADDRESS:
STREET 1: 4346 BELGIUM BLVD NW
CITY: RIVERSIDE
STATE: MO
ZIP: 64150
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001389545
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680454536
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 899-8800
MAIL ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-09-14
0001389545
NovaBay Pharmaceuticals, Inc.
NBY
0001738781
Kunin Audrey
C/O NOVABAY PHARMACEUTICALS, INC.
2000 POWELL STREET, SUITE 1150
EMERYVILLE
CA
94608
1
1
Chief Product Officer
Common Stock
2022-09-14
4
S
0
291368
0.1582
D
208632
I
See footnote
This transaction was executed in multiple trades at prices ranging from $0.1565 to $0.1605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.
/s/ Audrey Kunin
2022-09-16